EurekAlert! News by Subject: Medicine & Health

Medicine & Health

Updates every hour. Last Updated: 25-Oct-2026 20:16 ET (26-Oct-2026 00:16 GMT/UTC)

28-Jul-2026

Insilico Medicine announces oral presentation at ESMO 2026 for Phase 1 Clinical Study of ISM6331 in mesothelioma and advanced solid tumors

Presentation to feature first-in-human results for ISM6331, a novel, AI-designed pan-TEAD inhibitor targeting the Hippo pathway

Global Phase 1 multicenter study evaluates safety, tolerability, and preliminary efficacy in patients with mesothelioma and other advanced solid tumors

28-Jul-2026

Scientists develop a two-step system for detecting and classifying brain tumors from MRI images

University of Sharjah
Peer-Reviewed Publication

Researchers have developed a new artificial intelligence-based method that could significantly improve the speed and accuracy of brain tumor detection and classification from MRI scans.

Journal: Healthcare Analytics

28-Jul-2026

New study identifies behaviours influencing prescribing decisions for new medicines in neurodegenerative disease

Aston University
Peer-Reviewed Publication

A new pan-European study has identified the key behavioural factors that influence whether healthcare professionals prescribe new, novel or non-routine treatments for patients with neurodegenerative diseases.

Journal: PLOS One

28-Jul-2026

New course: IOF Musculoskeletal Rare Diseases Training Course: From Diagnosis to Care

International Osteoporosis Foundation
Business Announcement

The International Osteoporosis Foundation (IOF) announces the launch of the online IOF Musculoskeletal Rare Diseases Training Course: From Diagnosis to Care, now available on the IOF Academy to clinicians worldwide.

28-Jul-2026

Hidden sleep crisis among workers over 50, study suggests

University of Edinburgh
Peer-Reviewed Publication

Sleep disturbances are far more common among workers in mid-later life than previously believed, according to a study that links work-related stress to a range of wellbeing issues.

Journal: Scientific Reports

28-Jul-2026

Genetic risk factors of fibromyalgia identified in largest study of its kind

King's College London
Peer-Reviewed Publication

New genetic risk factors have been identified for fibromyalgia syndrome.

The landmark study, which involved scientists at King’s College London, published in Nature Medicine, highlights how the nervous system plays an important role in the development of the disorder.

Journal: Nature Medicine

28-Jul-2026

Ivermectin taken at the start of pregnancy is not associated with an increased risk of adverse pregnancy outcomes

Barcelona Institute for Global Health (ISGlobal)
Peer-Reviewed Publication

A study led by the Barcelona Institute for Global Health (ISGlobal), an institution supported by the ”la Caixa” Foundation, found no increased risk of miscarriage, stillbirth or major congenital anomalies among women inadvertently exposed to ivermectin during the period from two weeks before conception to the first four weeks of pregnancy.

Journal: EClinicalMedicine
Funder: Unitaid

28-Jul-2026

How our body's natural recycling system could help reduce inflammation

Vlaams Instituut voor Biotechnologie
Peer-Reviewed Publication

Researchers at the VIB and KU Leuven, together with international collaborators, have discovered that blocking autophagy – the body's natural recycling system for worn-out cell components – in specialized blood vessels can reduce inflammation in mice with psoriasis. Unlike many current therapies, this strategy reduces inflammation without weakening the immune system. The findings, published in the journal Immunity, reveal a promising new approach for treating chronic inflammatory and autoimmune diseases.

Journal: Immunity
Funder: ERC, FWO, German Research Foundation, iBOF Atlantis consortium, EOS MetaNiche consortium, NRW-Nachwuchsgruppenprogramm

28-Jul-2026

World Hepatitis Day 2026: Despite progress towards eliminating hepatitis in Europe, gaps in prevention measures keep 2030 targets out of reach

European Centre for Disease Prevention and Control (ECDC)
Reports and Proceedings

New ECDC data released for World Hepatitis Day shows that Europe has made significant progress against hepatitis B and C. However, uneven implementation of testing, vaccination, treatment and harm-reduction measures means the region is not on track to eliminate viral hepatitis as a public health threat by 2030.